# ACM Research, Inc. (ACMR) · Edgar & Edgarette company card

> ACM Research (ACMR) grew revenue 15.2% in FY2025 to $901 million, operating margin 12.1% against a 14.2% median for special industry machinery, equity 51.0% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1680062 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/ACMR) · [JSON](https://www.pops4.com/boards/company/ACMR.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $901M |
| Revenue growth, 1 year | 15.2% |
| Revenue growth per year | 36.5% |
| Operating margin | 12.1% (prior year 19.3%) |
| Net margin | 13.5% |
| Operating cash flow | −$10M |
| Capital spending | $56M |
| Free cash flow | −$67M |
| Cash | $757M |
| Long-term debt | $214M |
| Total assets | $2.9B |
| Total equity | $1.5B |
| Equity ÷ assets | 51.0% |
| Return on equity | 8.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 6.15 (safe zone)
- Piotroski F: 2 of 9 (weak)
- Beneish M: -1.99 (below the −1.78 line)
- Health Harbor boat: Sound ship · one warning sign · operating cash flow was negative
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $901.3M (FY2025), total debt $214.0M. Experience: revenue up 15.2% on the year, up 36.5% a year over 4 years; operating margin 12.1%, down from 19.3%. Soundness: equity 51.0% of assets, return on equity 8.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $914.7M and $1.3B next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $835.5M to $1.4B. A statistical range, not company guidance. Against peers (11 filers, $50M+ revenue, its industry group): operating margin 12.1% against a 14.2% median; growth 15.2% against 2.3%.

Range logged 2026-10-30, receipt 466a5def63a2c3e5, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 8-K · filed 2026-10-28 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1680062/000162828026067734/0001628280-26-067734-index.htm)
- 8-K · filed 2026-09-30 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1680062/000162828026063896/0001628280-26-063896-index.htm)
- 8-K · filed 2026-08-27 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1680062/000162828026059251/0001628280-26-059251-index.htm)
- 10-Q · filed 2026-08-07 · [filing](https://www.sec.gov/Archives/edgar/data/1680062/000162828026054832/0001628280-26-054832-index.htm)
- 8-K · filed 2026-08-07 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1680062/000162828026054581/0001628280-26-054581-index.htm)
- 8-K · filed 2026-06-22 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1680062/000162828026044506/0001628280-26-044506-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001680062.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1680062

## Cite

POPS4, Edgar & Edgarette: ACM Research, Inc. (ACMR) company card, from the company's own SEC filings, accessed 2026-11-03, https://www.pops4.com/boards/company/ACMR. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.